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Abstract
Postural Orthostatic Tachycardia Syndrome (POTS) is a form of 
dysautonomia and orthostatic intolerance which mainly affects young 
women between the ages of 18-50.  Current treatment options 
occasionally prove ineffective or inadvertently exacerbates symptoms. 
Therefore, this review analyzes the use of oral stimulants (I) for symptom 
management (O) in women ages 18-50 with refractory POTS (P) 
compared to standard medications (C).
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Introduction
Methods
Literature Search
• Performed in November 2018 using Google Scholar, PubMed, and 
Clinical Key
• Inclusion Criteria:
1. Published in peer-reviewed journal
2. Published in the last 5 years
3. Studies involving predominantly female population
4. Studies  evaluating the specific symptoms of chronic 
fatigue and/or cognitive impairment
• Exclusion Criteria:
1. Studies involving pediatrics
2. Alternative treatment options
3. Studies involving males
All studies report that amphetamine-based medication has improved 
symptoms in participants suffering from POTS that is refractory to 
standard treatment.  
Strengths
1. Overall positive results from all studies
2. In-depth data analysis
3. Minimal reported side effects
Limitations
1. Small sample sizes
2. Variation in the drug of choice among the selected studies
3. Minimal overlap in evaluated symptoms
4. Lack of double-blind studies
Future Research
1. Randomized double-blind studies
2. Studies investigating the effectiveness among amphetamines
3. Long-term effects of amphetamine use
Discussion Results 
The Efficacy of Amphetamines in the Treatment of Postural Orthostatic 
Tachycardia Syndrome
The five chosen studies all demonstrated promising results suggesting 
that amphetamines may be a safe and effective treatment for 
refractory POTS.  For patients suffering from refractory POTS that have 
failed standard treatments, amphetamines may provide a promising 
alternative to relieve life-altering symptoms.
However, more research needs to be completed in order to implement 
changes to the current treatment plan. Future research should focus 
on creating randomized, double-blind clinical trials that evaluate the 
efficacy of various amphetamine-based drugs amongst each other and 
long-term results of treatment.
The results of the meta-analysis are promising, however current data 
is inadequate to suggest a change to current treatment guidelines.
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Table 1 – Comparison of Results
Study Heart Rate 
Control
Symptom 
Control
Syncopal 
Episodes
BP Control Executive 
Functioning
Bernadzikowsk
i et al (2018) 
N/A S N/A N/A S
Grubb et al 
(2006)
S S S N/A N/A
Kpaeyeh et al 
(2014)
S S N/A S N/A
Kanjwal et al 
(2012)
N/A S S N/A N/A
Young, J.  
(2012)
S S N/A S S
Key: S – significant, NS – not significant, N/A – not available
Postural Orthostatic Tachycardia Syndrome (POTS)
Overview
• Characterized by a sustained heart rate increase of >30 beats/minute 
within ten minutes of standing with the absence of orthostatic 
hypotension
• Strong female predominance
• Estimated female to male ratio is 5:1
Symptoms
• Most symptoms are related to cerebral hypoperfusion
• Symptoms can include light-headedness, palpitations, presyncope, 
“mental fog”, sweating, tremors, anxiety, and fatigue
Treatment
• Current first line treatment includes fludrocortisone and beta-blockers
• Stimulants have been studied as a possible alternative to increase 
perfusion and thus mitigate symptoms
